6945.TWO · APBIO
Taiwan · RS rating 64 · As of 2026-10-08
| Price | 133.00 TWD |
|---|---|
| 1-day change | -5.0% |
| RS rating (overall / 1M / 3M / 12M) | 64 / 97 / 89 / 66 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 28 / 13 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -36.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +42.5% |
| Market cap (USD) | $415.4M |